South Carolina
Cancer clinical trials in South Carolina
176 cancer studies are recruiting participants at sites in 29 cities across South Carolina as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every South Carolina city with a recruiting study
By research area: Prostate Cancer (49), Lung Cancer (44), Breast Cancer (40), Lymphoma (30), Pancreatic Cancer (7), Melanoma (6).
Charleston (91), Greenville (67), Myrtle Beach (34), Greer (29), Boiling Springs (21), Seneca (21), Bluffton (19), Easley (19), Spartanburg (19), Hilton Head Island (14), Columbia (13), Gaffney (11), Rock Hill (11), Union (11), Georgetown (10), West Columbia (10), Florence (8), Anderson (7), Greenwood (4), Lancaster (4), Murrells Inlet (4), Beaufort (3), Clinton (2), North Charleston (2), Orangeburg (2), Hardeeville (1), Mt. Pleasant (1), Okatie (1), Summerville (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in South Carolina
Basic details from each study's public record (the 12 most recently updated of 176). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Greenville
- Registry record
- NCT06686394 · updated
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Recruiting in
- Greenville
- Registry record
- NCT03418961 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in South Carolina on ClinicalTrials.gov.
Lung cancer: recently updated in South Carolina
LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Medical University of South Carolina
- Recruiting in
- Charleston
- Registry record
- NCT07177846 · updated
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Myrtle Beach
- Registry record
- NCT03460977 · updated
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Phase 3
- Ages 18 to 100
- All sexes
- Sponsor
- Amgen
- Recruiting in
- Lancaster
- Registry record
- NCT05920356 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in South Carolina on ClinicalTrials.gov.
Prostate cancer: recently updated in South Carolina
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Charleston
- Registry record
- NCT05011383 · updated
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Charleston
- Registry record
- NCT04423211 · updated
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Recruiting in
- Charleston · Myrtle Beach
- Registry record
- NCT07190300 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in South Carolina on ClinicalTrials.gov.
Melanoma: recently updated in South Carolina
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Charleston
- Registry record
- NCT07068074 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in South Carolina on ClinicalTrials.gov.
Lymphoma: recently updated in South Carolina
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eastern Cooperative Oncology Group
- Recruiting in
- Charleston
- Registry record
- NCT06724237 · updated
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Greenville
- Registry record
- NCT06717347 · updated
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Charleston
- Registry record
- NCT06890884 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in South Carolina on ClinicalTrials.gov.
Ask about studies in South Carolina
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections